M. Bennet Broner is a medical ethicist.
The Food and Drug Administration (FDA) negated the recommendation of its expert panel and approved Aduhelm to treat Alzheimer’s dementia (AD), contending that the possible benefit trumped the lack of evidence of efficacy. The FDA was inexcusably in error in making this decision. Aside from the likely lack of benefit, the use of this drug can result in many negative consequences that make its use ethically questionable.
The manufacturer submitted two …
About a year ago, I was referred to a sleep clinic and was diagnosed with “very mild obstructive sleep apnoea” (OSA). A continuous positive airway pressure (CPAP) device was recommended with a litany of disorders that would occur (heart disease, CVA, HTN, decreased mortality, motor vehicle accidents, etc.) if I did not use the apparatus consistently and properly.
I assiduously used it for two test periods. Though the physician reported improvement, …
Recently, there have been several TV advertisements on cancer treatments that may extend life. They report survival data that can mislead cancer victims to the extent of possible longevity. Additionally, they present a false picture of how life can be spent.
I have strong reservations regarding medication advertising to the public. Its purpose is to increase profits, not medical education. I know that businesses gamble significant amounts of money on drug …
I recently read an opinion by a physician regarding the decision as to which COVID patient would receive care and which would not when hospitals became too full to care for every patient. He suggested that no one need be denied care if some structural changes were made in health care delivery. Given the expected post-Christmas/New Year tsunami of new cases; and limited supplies, equipment, and staff, it is doubtful …
Get free updates delivered free to your inbox.
